prof. dr. L. (Linde) Meyaard Full Professor
- Laboratory for Translational Immunology (LTI)
Linde Meyaard obtained her PhD in 1995 (cum laude) at Sanquin in Amsterdam studying mechanism of immune dysfunction in HIV infection. In 1996 she entered the immune inhibitory receptor field as a post-doc at DNAX Research Institute in California. She identified a novel inhibitory immune receptor, LAIR-1, and continued her work on this receptor in as a fellow of the Royal Academy of Sciences (KNAW) in the UMC Utrecht.
Since 2000 she leads her own research group embedded in the Laboratory of Translational Immunology, supported by multiple grants such as the NWO Vidi and Vici. Meyaard was the first to identify collagens and collagen-like proteins as the natural ligands for LAIR-1.
She extended her research towards other inhibitory receptors and discovered SIRL-1 as a novel receptor able to regulate the function of neutrophils and monocytes.
Currently, Meyaard focuses on studying the control of immune-mediated collateral tissue damage through inhibitory receptors in human disease. She formes a translational research team with clinician Professor Louis Bont, studying regulation of neutrophilic airway inflammation and the potential to therapeutically exploit inhibitory receptors. The growing global interest in targeting inhibitory receptors therapeutically opens up possibilities for clinical application of her work.
Visiting Scientist, Yale Medical School, Dept Immunobiology Aug 2016 → 31 Jul 2017
Secretary general of the Dutch Society of Immunology
Member of review panel NWO/ALW Open Program
Associate Editor Frontiers in Molecular Innate Immunity
Review Editor Frontiers in NK Cell Biology
Member of the ZonMW TOP program review committee
Member of the Scientific Advisory Board of the Dutch Arthritis Foundation
Fellowship and Awards
1999-2001 Fellow of the Royal Dutch Academy of Science (KNAW)
2001 NWO Vidi
2002 NWO Aspasia
2014 NWO Vici